PRESS RELEASE
BUSINESS WIRE: Junevity, a biotechnology company on a mission to extend lifespan and healthspan with siRNA (silencing RNA) therapeutics, today announced co-founder and chief scientific officer Dr. Janine Sengstack will be presenting the first ever data demonstrating that siRNA therapeutics can restore global gene networks to a healthier state in vivo.
